ArticleFrontiers in medicine2026

TNM stage I pancreatic ductal adenocarcinoma patients without pathological risk may drive limited benefit from adjuvant chemotherapy.

Zhifei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.